NCT02068092View on ClinicalTrials.gov

Olive Oil for High Risk Breast Cancer Prevention in Women

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Breast Cancer
Interventions
DRUG

Hydroxytyrosol

Trial Locations (3)

77030

Houston Methodist Hospital, Houston

77070

Houston Methodist Hospital Willowbrook, Houston

77479

Houston Methodist Hospital Sugar Land, Sugar Land

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER

NCT02068092 - Olive Oil for High Risk Breast Cancer Prevention in Women | Biotech Hunter | Biotech Hunter